nodes	percent_of_prediction	percent_of_DWPC	metapath
Quinine—CYP1A1—kidney cancer	0.174	0.653	CbGaD
Quinine—ABCB1—kidney cancer	0.0926	0.347	CbGaD
Quinine—CYP3A7—Temsirolimus—kidney cancer	0.031	0.0618	CbGbCtD
Quinine—CYP3A7-CYP3A51P—Temsirolimus—kidney cancer	0.031	0.0618	CbGbCtD
Quinine—SLC22A5—Dactinomycin—kidney cancer	0.0287	0.0571	CbGbCtD
Quinine—CYP3A5—Temsirolimus—kidney cancer	0.0233	0.0463	CbGbCtD
Quinine—SLC22A2—Vinblastine—kidney cancer	0.0171	0.0341	CbGbCtD
Quinine—ABCB1—Temsirolimus—kidney cancer	0.0152	0.0302	CbGbCtD
Quinine—KCNH2—Sunitinib—kidney cancer	0.015	0.0298	CbGbCtD
Quinine—CYP1A1—Erlotinib—kidney cancer	0.0145	0.0289	CbGbCtD
Quinine—CYP2D6—Temsirolimus—kidney cancer	0.0143	0.0284	CbGbCtD
Quinine—CYP3A4—Everolimus—kidney cancer	0.0134	0.0267	CbGbCtD
Quinine—CYP2C8—Pazopanib—kidney cancer	0.0118	0.0234	CbGbCtD
Quinine—CYP3A7—Paclitaxel—kidney cancer	0.0107	0.0212	CbGbCtD
Quinine—CYP3A7-CYP3A51P—Paclitaxel—kidney cancer	0.0107	0.0212	CbGbCtD
Quinine—CYP3A7-CYP3A51P—Sorafenib—kidney cancer	0.00946	0.0188	CbGbCtD
Quinine—CYP3A7—Sorafenib—kidney cancer	0.00946	0.0188	CbGbCtD
Quinine—CYP3A7-CYP3A51P—Vincristine—kidney cancer	0.00919	0.0183	CbGbCtD
Quinine—CYP3A7—Vincristine—kidney cancer	0.00919	0.0183	CbGbCtD
Quinine—CYP1A2—Pazopanib—kidney cancer	0.00911	0.0181	CbGbCtD
Quinine—CYP3A4—Temsirolimus—kidney cancer	0.00908	0.0181	CbGbCtD
Quinine—CYP3A5—Erlotinib—kidney cancer	0.00873	0.0174	CbGbCtD
Quinine—CYP2C9—Capecitabine—kidney cancer	0.00856	0.017	CbGbCtD
Quinine—CYP2C8—Erlotinib—kidney cancer	0.00839	0.0167	CbGbCtD
Quinine—CYP3A5—Paclitaxel—kidney cancer	0.00799	0.0159	CbGbCtD
Quinine—ABCB1—Pazopanib—kidney cancer	0.00796	0.0158	CbGbCtD
Quinine—CYP2C8—Paclitaxel—kidney cancer	0.00768	0.0153	CbGbCtD
Quinine—CYP3A7-CYP3A51P—Sunitinib—kidney cancer	0.00767	0.0153	CbGbCtD
Quinine—CYP3A7—Sunitinib—kidney cancer	0.00767	0.0153	CbGbCtD
Quinine—CYP2D6—Pazopanib—kidney cancer	0.0075	0.0149	CbGbCtD
Quinine—ABCB1—Dactinomycin—kidney cancer	0.00728	0.0145	CbGbCtD
Quinine—CYP3A5—Sorafenib—kidney cancer	0.0071	0.0141	CbGbCtD
Quinine—CYP3A5—Vincristine—kidney cancer	0.00689	0.0137	CbGbCtD
Quinine—CYP2C8—Sorafenib—kidney cancer	0.00682	0.0136	CbGbCtD
Quinine—CYP1A2—Erlotinib—kidney cancer	0.0065	0.0129	CbGbCtD
Quinine—ABCB1—Gemcitabine—kidney cancer	0.00576	0.0115	CbGbCtD
Quinine—CYP3A5—Sunitinib—kidney cancer	0.00575	0.0114	CbGbCtD
Quinine—CYP2C19—Sorafenib—kidney cancer	0.00573	0.0114	CbGbCtD
Quinine—ABCB1—Erlotinib—kidney cancer	0.00568	0.0113	CbGbCtD
Quinine—CYP2C9—Paclitaxel—kidney cancer	0.00536	0.0107	CbGbCtD
Quinine—CYP2D6—Erlotinib—kidney cancer	0.00535	0.0107	CbGbCtD
Quinine—CYP1A2—Sorafenib—kidney cancer	0.00528	0.0105	CbGbCtD
Quinine—ABCB1—Paclitaxel—kidney cancer	0.0052	0.0103	CbGbCtD
Quinine—CYP3A4—Pazopanib—kidney cancer	0.00477	0.00949	CbGbCtD
Quinine—CYP2C9—Sorafenib—kidney cancer	0.00476	0.00947	CbGbCtD
Quinine—SLC22A2—nephron—kidney cancer	0.00463	0.132	CbGeAlD
Quinine—ABCB1—Sorafenib—kidney cancer	0.00462	0.00919	CbGbCtD
Quinine—ABCB1—Vinblastine—kidney cancer	0.00456	0.00908	CbGbCtD
Quinine—ABCB1—Vincristine—kidney cancer	0.00448	0.00892	CbGbCtD
Quinine—CYP2D6—Sorafenib—kidney cancer	0.00435	0.00866	CbGbCtD
Quinine—CYP2D6—Vinblastine—kidney cancer	0.0043	0.00855	CbGbCtD
Quinine—ABCB1—Sunitinib—kidney cancer	0.00374	0.00745	CbGbCtD
Quinine—CYP3A4—Erlotinib—kidney cancer	0.0034	0.00677	CbGbCtD
Quinine—CYP3A4—Paclitaxel—kidney cancer	0.00312	0.0062	CbGbCtD
Quinine—ABCB1—Doxorubicin—kidney cancer	0.0028	0.00558	CbGbCtD
Quinine—CYP3A4—Sorafenib—kidney cancer	0.00277	0.00551	CbGbCtD
Quinine—CYP3A4—Vinblastine—kidney cancer	0.00273	0.00544	CbGbCtD
Quinine—CYP3A4—Vincristine—kidney cancer	0.00269	0.00535	CbGbCtD
Quinine—CYP2D6—Doxorubicin—kidney cancer	0.00264	0.00525	CbGbCtD
Quinine—CYP3A4—Sunitinib—kidney cancer	0.00224	0.00446	CbGbCtD
Quinine—SLC22A5—Temsirolimus—Everolimus—kidney cancer	0.0021	1	CbGdCrCtD
Quinine—CYP2C19—urine—kidney cancer	0.00202	0.0576	CbGeAlD
Quinine—CYP3A4—Doxorubicin—kidney cancer	0.00168	0.00334	CbGbCtD
Quinine—CYP1A2—urine—kidney cancer	0.00165	0.047	CbGeAlD
Quinine—CYP2C9—urine—kidney cancer	0.00157	0.0446	CbGeAlD
Quinine—CYP2E1—urine—kidney cancer	0.00149	0.0423	CbGeAlD
Quinine—CYP3A4—urine—kidney cancer	0.0012	0.034	CbGeAlD
Quinine—CYP2D6—urine—kidney cancer	0.00118	0.0335	CbGeAlD
Quinine—CYP3A7-CYP3A51P—nephron tubule—kidney cancer	0.00104	0.0295	CbGeAlD
Quinine—SLC22A2—nephron tubule—kidney cancer	0.000999	0.0285	CbGeAlD
Quinine—SLC22A2—renal system—kidney cancer	0.000908	0.0259	CbGeAlD
Quinine—CYP3A7-CYP3A51P—cortex of kidney—kidney cancer	0.000886	0.0252	CbGeAlD
Quinine—SLC22A2—kidney—kidney cancer	0.000878	0.025	CbGeAlD
Quinine—SLC22A2—cortex of kidney—kidney cancer	0.000855	0.0244	CbGeAlD
Quinine—SLC22A4—nephron tubule—kidney cancer	0.000741	0.0211	CbGeAlD
Quinine—SLC22A4—renal system—kidney cancer	0.000674	0.0192	CbGeAlD
Quinine—SLC22A4—kidney—kidney cancer	0.000651	0.0186	CbGeAlD
Quinine—SLC22A1—renal system—kidney cancer	0.000642	0.0183	CbGeAlD
Quinine—Quinidine—CYP1A1—kidney cancer	0.00064	0.653	CrCbGaD
Quinine—SLC22A4—cortex of kidney—kidney cancer	0.000634	0.0181	CbGeAlD
Quinine—SLC22A1—kidney—kidney cancer	0.00062	0.0177	CbGeAlD
Quinine—SLCO1A2—renal system—kidney cancer	0.000618	0.0176	CbGeAlD
Quinine—SLCO1A2—kidney—kidney cancer	0.000597	0.017	CbGeAlD
Quinine—SLC22A5—nephron tubule—kidney cancer	0.000491	0.014	CbGeAlD
Quinine—KCNH2—renal system—kidney cancer	0.000472	0.0134	CbGeAlD
Quinine—SLC22A5—renal system—kidney cancer	0.000446	0.0127	CbGeAlD
Quinine—CYP2C8—renal system—kidney cancer	0.000432	0.0123	CbGeAlD
Quinine—SLC22A5—kidney—kidney cancer	0.000431	0.0123	CbGeAlD
Quinine—CYP3A5—nephron tubule—kidney cancer	0.000429	0.0122	CbGeAlD
Quinine—KCNH2—cardiac atrium—kidney cancer	0.000423	0.012	CbGeAlD
Quinine—SLC22A5—cortex of kidney—kidney cancer	0.00042	0.012	CbGeAlD
Quinine—CYP2C8—kidney—kidney cancer	0.000417	0.0119	CbGeAlD
Quinine—CYP1A2—renal system—kidney cancer	0.000404	0.0115	CbGeAlD
Quinine—CYP2E1—nephron tubule—kidney cancer	0.0004	0.0114	CbGeAlD
Quinine—SLC22A5—cardiac atrium—kidney cancer	0.000399	0.0114	CbGeAlD
Quinine—CYP1A1—renal system—kidney cancer	0.000398	0.0113	CbGeAlD
Quinine—CYP3A5—renal system—kidney cancer	0.00039	0.0111	CbGeAlD
Quinine—CYP1A1—kidney—kidney cancer	0.000385	0.011	CbGeAlD
Quinine—CYP3A5—kidney—kidney cancer	0.000377	0.0107	CbGeAlD
Quinine—CYP3A5—cortex of kidney—kidney cancer	0.000367	0.0104	CbGeAlD
Quinine—CYP2E1—renal system—kidney cancer	0.000363	0.0103	CbGeAlD
Quinine—CYP1A1—cardiac atrium—kidney cancer	0.000357	0.0102	CbGeAlD
Quinine—CYP2E1—kidney—kidney cancer	0.000351	0.01	CbGeAlD
Quinine—CYP2E1—cortex of kidney—kidney cancer	0.000342	0.00974	CbGeAlD
Quinine—Quinidine—ABCB1—kidney cancer	0.00034	0.347	CrCbGaD
Quinine—CYP3A4—renal system—kidney cancer	0.000292	0.00833	CbGeAlD
Quinine—CYP2D6—renal system—kidney cancer	0.000288	0.00819	CbGeAlD
Quinine—CYP3A4—kidney—kidney cancer	0.000283	0.00805	CbGeAlD
Quinine—CYP2D6—kidney—kidney cancer	0.000278	0.00792	CbGeAlD
Quinine—ABCB1—nephron tubule—kidney cancer	0.000228	0.00648	CbGeAlD
Quinine—ABCB1—renal system—kidney cancer	0.000207	0.00589	CbGeAlD
Quinine—ABCB1—kidney—kidney cancer	0.0002	0.0057	CbGeAlD
Quinine—ABCB1—cortex of kidney—kidney cancer	0.000195	0.00555	CbGeAlD
Quinine—ABCB1—gonad—kidney cancer	0.000186	0.00529	CbGeAlD
Quinine—Gastrointestinal pain—Dactinomycin—kidney cancer	9.6e-05	0.000668	CcSEcCtD
Quinine—Tremor—Paclitaxel—kidney cancer	9.56e-05	0.000666	CcSEcCtD
Quinine—Musculoskeletal discomfort—Vincristine—kidney cancer	9.56e-05	0.000665	CcSEcCtD
Quinine—Urinary tract disorder—Capecitabine—kidney cancer	9.5e-05	0.000662	CcSEcCtD
Quinine—Dermatitis exfoliative—Doxorubicin—kidney cancer	9.5e-05	0.000662	CcSEcCtD
Quinine—Hypersensitivity—Sorafenib—kidney cancer	9.5e-05	0.000661	CcSEcCtD
Quinine—Anorexia—Gemcitabine—kidney cancer	9.49e-05	0.00066	CcSEcCtD
Quinine—Vomiting—Vinblastine—kidney cancer	9.48e-05	0.00066	CcSEcCtD
Quinine—Dizziness—Erlotinib—kidney cancer	9.47e-05	0.00066	CcSEcCtD
Quinine—Vomiting—Everolimus—kidney cancer	9.44e-05	0.000657	CcSEcCtD
Quinine—Urethral disorder—Capecitabine—kidney cancer	9.43e-05	0.000657	CcSEcCtD
Quinine—Renal impairment—Doxorubicin—kidney cancer	9.42e-05	0.000656	CcSEcCtD
Quinine—Dermatitis bullous—Doxorubicin—kidney cancer	9.38e-05	0.000653	CcSEcCtD
Quinine—Agitation—Paclitaxel—kidney cancer	9.38e-05	0.000653	CcSEcCtD
Quinine—Rash—Everolimus—kidney cancer	9.36e-05	0.000652	CcSEcCtD
Quinine—Dermatitis—Everolimus—kidney cancer	9.35e-05	0.000651	CcSEcCtD
Quinine—Headache—Vinblastine—kidney cancer	9.34e-05	0.00065	CcSEcCtD
Quinine—Angioedema—Paclitaxel—kidney cancer	9.33e-05	0.000649	CcSEcCtD
Quinine—Purpura—Doxorubicin—kidney cancer	9.3e-05	0.000648	CcSEcCtD
Quinine—Headache—Everolimus—kidney cancer	9.3e-05	0.000648	CcSEcCtD
Quinine—Hypotension—Gemcitabine—kidney cancer	9.3e-05	0.000647	CcSEcCtD
Quinine—Body temperature increased—Dactinomycin—kidney cancer	9.28e-05	0.000646	CcSEcCtD
Quinine—Abdominal pain—Dactinomycin—kidney cancer	9.28e-05	0.000646	CcSEcCtD
Quinine—Visual impairment—Capecitabine—kidney cancer	9.27e-05	0.000646	CcSEcCtD
Quinine—Asthenia—Sorafenib—kidney cancer	9.25e-05	0.000644	CcSEcCtD
Quinine—Hypoglycaemia—Doxorubicin—kidney cancer	9.19e-05	0.00064	CcSEcCtD
Quinine—Vertigo—Paclitaxel—kidney cancer	9.17e-05	0.000639	CcSEcCtD
Quinine—Syncope—Paclitaxel—kidney cancer	9.16e-05	0.000637	CcSEcCtD
Quinine—Leukopenia—Paclitaxel—kidney cancer	9.14e-05	0.000636	CcSEcCtD
Quinine—Hypersensitivity—Sunitinib—kidney cancer	9.14e-05	0.000636	CcSEcCtD
Quinine—Decreased appetite—Vincristine—kidney cancer	9.12e-05	0.000635	CcSEcCtD
Quinine—Pruritus—Sorafenib—kidney cancer	9.12e-05	0.000635	CcSEcCtD
Quinine—Vomiting—Erlotinib—kidney cancer	9.11e-05	0.000634	CcSEcCtD
Quinine—Erythema multiforme—Capecitabine—kidney cancer	9.1e-05	0.000633	CcSEcCtD
Quinine—Musculoskeletal discomfort—Gemcitabine—kidney cancer	9.07e-05	0.000631	CcSEcCtD
Quinine—Gastrointestinal disorder—Vincristine—kidney cancer	9.06e-05	0.00063	CcSEcCtD
Quinine—Rash—Erlotinib—kidney cancer	9.03e-05	0.000629	CcSEcCtD
Quinine—Dermatitis—Erlotinib—kidney cancer	9.02e-05	0.000628	CcSEcCtD
Quinine—Palpitations—Paclitaxel—kidney cancer	9.02e-05	0.000628	CcSEcCtD
Quinine—Eye disorder—Capecitabine—kidney cancer	8.99e-05	0.000626	CcSEcCtD
Quinine—Headache—Erlotinib—kidney cancer	8.98e-05	0.000625	CcSEcCtD
Quinine—Tinnitus—Capecitabine—kidney cancer	8.97e-05	0.000625	CcSEcCtD
Quinine—Loss of consciousness—Paclitaxel—kidney cancer	8.97e-05	0.000625	CcSEcCtD
Quinine—Diplopia—Doxorubicin—kidney cancer	8.97e-05	0.000624	CcSEcCtD
Quinine—Flushing—Capecitabine—kidney cancer	8.93e-05	0.000622	CcSEcCtD
Quinine—Cardiac disorder—Capecitabine—kidney cancer	8.93e-05	0.000622	CcSEcCtD
Quinine—Asthenia—Sunitinib—kidney cancer	8.9e-05	0.000619	CcSEcCtD
Quinine—Dyspnoea—Gemcitabine—kidney cancer	8.87e-05	0.000618	CcSEcCtD
Quinine—Nausea—Vinblastine—kidney cancer	8.85e-05	0.000616	CcSEcCtD
Quinine—Convulsion—Paclitaxel—kidney cancer	8.85e-05	0.000616	CcSEcCtD
Quinine—Nausea—Everolimus—kidney cancer	8.82e-05	0.000614	CcSEcCtD
Quinine—Diarrhoea—Sorafenib—kidney cancer	8.82e-05	0.000614	CcSEcCtD
Quinine—Pruritus—Sunitinib—kidney cancer	8.77e-05	0.000611	CcSEcCtD
Quinine—Immune system disorder—Capecitabine—kidney cancer	8.69e-05	0.000605	CcSEcCtD
Quinine—Myalgia—Paclitaxel—kidney cancer	8.69e-05	0.000605	CcSEcCtD
Quinine—Chest pain—Paclitaxel—kidney cancer	8.69e-05	0.000605	CcSEcCtD
Quinine—Mediastinal disorder—Capecitabine—kidney cancer	8.67e-05	0.000604	CcSEcCtD
Quinine—Decreased appetite—Gemcitabine—kidney cancer	8.65e-05	0.000602	CcSEcCtD
Quinine—Hypersensitivity—Dactinomycin—kidney cancer	8.65e-05	0.000602	CcSEcCtD
Quinine—Chills—Capecitabine—kidney cancer	8.64e-05	0.000601	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Paclitaxel—kidney cancer	8.63e-05	0.000601	CcSEcCtD
Quinine—Gastrointestinal disorder—Gemcitabine—kidney cancer	8.59e-05	0.000598	CcSEcCtD
Quinine—Gastrointestinal pain—Vincristine—kidney cancer	8.58e-05	0.000597	CcSEcCtD
Quinine—Cardiac arrest—Doxorubicin—kidney cancer	8.53e-05	0.000594	CcSEcCtD
Quinine—Dizziness—Sorafenib—kidney cancer	8.52e-05	0.000593	CcSEcCtD
Quinine—Nausea—Erlotinib—kidney cancer	8.51e-05	0.000592	CcSEcCtD
Quinine—Diarrhoea—Sunitinib—kidney cancer	8.49e-05	0.000591	CcSEcCtD
Quinine—Ataxia—Doxorubicin—kidney cancer	8.43e-05	0.000587	CcSEcCtD
Quinine—Mental disorder—Capecitabine—kidney cancer	8.43e-05	0.000587	CcSEcCtD
Quinine—Asthenia—Dactinomycin—kidney cancer	8.42e-05	0.000586	CcSEcCtD
Quinine—Confusional state—Paclitaxel—kidney cancer	8.4e-05	0.000585	CcSEcCtD
Quinine—Malnutrition—Capecitabine—kidney cancer	8.38e-05	0.000583	CcSEcCtD
Quinine—Erythema—Capecitabine—kidney cancer	8.38e-05	0.000583	CcSEcCtD
Quinine—Oedema—Paclitaxel—kidney cancer	8.33e-05	0.00058	CcSEcCtD
Quinine—Body temperature increased—Vincristine—kidney cancer	8.29e-05	0.000577	CcSEcCtD
Quinine—Abdominal pain—Vincristine—kidney cancer	8.29e-05	0.000577	CcSEcCtD
Quinine—Liver function test abnormal—Doxorubicin—kidney cancer	8.28e-05	0.000576	CcSEcCtD
Quinine—Dizziness—Sunitinib—kidney cancer	8.2e-05	0.000571	CcSEcCtD
Quinine—Feeling abnormal—Gemcitabine—kidney cancer	8.2e-05	0.000571	CcSEcCtD
Quinine—Shock—Paclitaxel—kidney cancer	8.2e-05	0.000571	CcSEcCtD
Quinine—Vomiting—Sorafenib—kidney cancer	8.2e-05	0.00057	CcSEcCtD
Quinine—Abdominal pain upper—Doxorubicin—kidney cancer	8.19e-05	0.00057	CcSEcCtD
Quinine—Orthostatic hypotension—Doxorubicin—kidney cancer	8.19e-05	0.00057	CcSEcCtD
Quinine—Nervous system disorder—Paclitaxel—kidney cancer	8.17e-05	0.000569	CcSEcCtD
Quinine—Thrombocytopenia—Paclitaxel—kidney cancer	8.16e-05	0.000568	CcSEcCtD
Quinine—Tachycardia—Paclitaxel—kidney cancer	8.13e-05	0.000566	CcSEcCtD
Quinine—Rash—Sorafenib—kidney cancer	8.13e-05	0.000566	CcSEcCtD
Quinine—Dermatitis—Sorafenib—kidney cancer	8.12e-05	0.000565	CcSEcCtD
Quinine—Breast disorder—Doxorubicin—kidney cancer	8.1e-05	0.000564	CcSEcCtD
Quinine—Skin disorder—Paclitaxel—kidney cancer	8.09e-05	0.000563	CcSEcCtD
Quinine—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	8.08e-05	0.000562	CcSEcCtD
Quinine—Headache—Sorafenib—kidney cancer	8.07e-05	0.000562	CcSEcCtD
Quinine—Hyperhidrosis—Paclitaxel—kidney cancer	8.05e-05	0.000561	CcSEcCtD
Quinine—Diarrhoea—Dactinomycin—kidney cancer	8.03e-05	0.000559	CcSEcCtD
Quinine—Anorexia—Paclitaxel—kidney cancer	7.94e-05	0.000553	CcSEcCtD
Quinine—Muscular weakness—Doxorubicin—kidney cancer	7.91e-05	0.000551	CcSEcCtD
Quinine—Vision blurred—Capecitabine—kidney cancer	7.9e-05	0.00055	CcSEcCtD
Quinine—Vomiting—Sunitinib—kidney cancer	7.89e-05	0.000549	CcSEcCtD
Quinine—Body temperature increased—Gemcitabine—kidney cancer	7.87e-05	0.000548	CcSEcCtD
Quinine—Tremor—Capecitabine—kidney cancer	7.85e-05	0.000546	CcSEcCtD
Quinine—Rash—Sunitinib—kidney cancer	7.82e-05	0.000544	CcSEcCtD
Quinine—Dermatitis—Sunitinib—kidney cancer	7.81e-05	0.000544	CcSEcCtD
Quinine—Hypotension—Paclitaxel—kidney cancer	7.79e-05	0.000542	CcSEcCtD
Quinine—Headache—Sunitinib—kidney cancer	7.77e-05	0.000541	CcSEcCtD
Quinine—Asthma—Doxorubicin—kidney cancer	7.75e-05	0.00054	CcSEcCtD
Quinine—Hypersensitivity—Vincristine—kidney cancer	7.73e-05	0.000538	CcSEcCtD
Quinine—Nausea—Sorafenib—kidney cancer	7.66e-05	0.000533	CcSEcCtD
Quinine—Musculoskeletal discomfort—Paclitaxel—kidney cancer	7.59e-05	0.000528	CcSEcCtD
Quinine—Angina pectoris—Doxorubicin—kidney cancer	7.55e-05	0.000526	CcSEcCtD
Quinine—Vertigo—Capecitabine—kidney cancer	7.53e-05	0.000524	CcSEcCtD
Quinine—Asthenia—Vincristine—kidney cancer	7.53e-05	0.000524	CcSEcCtD
Quinine—Syncope—Capecitabine—kidney cancer	7.51e-05	0.000523	CcSEcCtD
Quinine—Leukopenia—Capecitabine—kidney cancer	7.5e-05	0.000522	CcSEcCtD
Quinine—Vomiting—Dactinomycin—kidney cancer	7.47e-05	0.00052	CcSEcCtD
Quinine—Dyspnoea—Paclitaxel—kidney cancer	7.43e-05	0.000517	CcSEcCtD
Quinine—Palpitations—Capecitabine—kidney cancer	7.4e-05	0.000515	CcSEcCtD
Quinine—Rash—Dactinomycin—kidney cancer	7.4e-05	0.000515	CcSEcCtD
Quinine—Nausea—Sunitinib—kidney cancer	7.37e-05	0.000513	CcSEcCtD
Quinine—Loss of consciousness—Capecitabine—kidney cancer	7.36e-05	0.000513	CcSEcCtD
Quinine—Pancytopenia—Doxorubicin—kidney cancer	7.36e-05	0.000512	CcSEcCtD
Quinine—Neutropenia—Doxorubicin—kidney cancer	7.25e-05	0.000505	CcSEcCtD
Quinine—Decreased appetite—Paclitaxel—kidney cancer	7.24e-05	0.000504	CcSEcCtD
Quinine—Gastrointestinal disorder—Paclitaxel—kidney cancer	7.19e-05	0.000501	CcSEcCtD
Quinine—Diarrhoea—Vincristine—kidney cancer	7.18e-05	0.0005	CcSEcCtD
Quinine—Asthenia—Gemcitabine—kidney cancer	7.14e-05	0.000497	CcSEcCtD
Quinine—Chest pain—Capecitabine—kidney cancer	7.13e-05	0.000497	CcSEcCtD
Quinine—Myalgia—Capecitabine—kidney cancer	7.13e-05	0.000497	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	7.08e-05	0.000493	CcSEcCtD
Quinine—Photosensitivity reaction—Doxorubicin—kidney cancer	7.07e-05	0.000492	CcSEcCtD
Quinine—Pruritus—Gemcitabine—kidney cancer	7.04e-05	0.00049	CcSEcCtD
Quinine—Nausea—Dactinomycin—kidney cancer	6.97e-05	0.000485	CcSEcCtD
Quinine—Dizziness—Vincristine—kidney cancer	6.94e-05	0.000483	CcSEcCtD
Quinine—Confusional state—Capecitabine—kidney cancer	6.89e-05	0.00048	CcSEcCtD
Quinine—Feeling abnormal—Paclitaxel—kidney cancer	6.87e-05	0.000478	CcSEcCtD
Quinine—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	6.85e-05	0.000477	CcSEcCtD
Quinine—Oedema—Capecitabine—kidney cancer	6.84e-05	0.000476	CcSEcCtD
Quinine—Gastrointestinal pain—Paclitaxel—kidney cancer	6.81e-05	0.000474	CcSEcCtD
Quinine—Diarrhoea—Gemcitabine—kidney cancer	6.81e-05	0.000474	CcSEcCtD
Quinine—Renal failure—Doxorubicin—kidney cancer	6.79e-05	0.000473	CcSEcCtD
Quinine—Jaundice—Doxorubicin—kidney cancer	6.74e-05	0.000469	CcSEcCtD
Quinine—Shock—Capecitabine—kidney cancer	6.73e-05	0.000468	CcSEcCtD
Quinine—Nervous system disorder—Capecitabine—kidney cancer	6.71e-05	0.000467	CcSEcCtD
Quinine—Thrombocytopenia—Capecitabine—kidney cancer	6.69e-05	0.000466	CcSEcCtD
Quinine—Tachycardia—Capecitabine—kidney cancer	6.67e-05	0.000465	CcSEcCtD
Quinine—Vomiting—Vincristine—kidney cancer	6.67e-05	0.000464	CcSEcCtD
Quinine—Skin disorder—Capecitabine—kidney cancer	6.64e-05	0.000462	CcSEcCtD
Quinine—Sweating—Doxorubicin—kidney cancer	6.63e-05	0.000461	CcSEcCtD
Quinine—Urticaria—Paclitaxel—kidney cancer	6.62e-05	0.000461	CcSEcCtD
Quinine—Rash—Vincristine—kidney cancer	6.61e-05	0.00046	CcSEcCtD
Quinine—Hyperhidrosis—Capecitabine—kidney cancer	6.61e-05	0.00046	CcSEcCtD
Quinine—Dermatitis—Vincristine—kidney cancer	6.61e-05	0.00046	CcSEcCtD
Quinine—Abdominal pain—Paclitaxel—kidney cancer	6.59e-05	0.000459	CcSEcCtD
Quinine—Body temperature increased—Paclitaxel—kidney cancer	6.59e-05	0.000459	CcSEcCtD
Quinine—Headache—Vincristine—kidney cancer	6.57e-05	0.000457	CcSEcCtD
Quinine—Anorexia—Capecitabine—kidney cancer	6.52e-05	0.000454	CcSEcCtD
Quinine—Agranulocytosis—Doxorubicin—kidney cancer	6.45e-05	0.000449	CcSEcCtD
Quinine—Hypotension—Capecitabine—kidney cancer	6.39e-05	0.000445	CcSEcCtD
Quinine—Vomiting—Gemcitabine—kidney cancer	6.33e-05	0.00044	CcSEcCtD
Quinine—Bradycardia—Doxorubicin—kidney cancer	6.32e-05	0.00044	CcSEcCtD
Quinine—Rash—Gemcitabine—kidney cancer	6.27e-05	0.000437	CcSEcCtD
Quinine—Dermatitis—Gemcitabine—kidney cancer	6.27e-05	0.000436	CcSEcCtD
Quinine—Haemoglobin—Doxorubicin—kidney cancer	6.24e-05	0.000434	CcSEcCtD
Quinine—Headache—Gemcitabine—kidney cancer	6.23e-05	0.000434	CcSEcCtD
Quinine—Nausea—Vincristine—kidney cancer	6.23e-05	0.000434	CcSEcCtD
Quinine—Musculoskeletal discomfort—Capecitabine—kidney cancer	6.23e-05	0.000434	CcSEcCtD
Quinine—Hepatitis—Doxorubicin—kidney cancer	6.2e-05	0.000432	CcSEcCtD
Quinine—Haemorrhage—Doxorubicin—kidney cancer	6.2e-05	0.000432	CcSEcCtD
Quinine—Hypersensitivity—Paclitaxel—kidney cancer	6.14e-05	0.000427	CcSEcCtD
Quinine—Urinary tract disorder—Doxorubicin—kidney cancer	6.13e-05	0.000426	CcSEcCtD
Quinine—Dyspnoea—Capecitabine—kidney cancer	6.1e-05	0.000424	CcSEcCtD
Quinine—Urethral disorder—Doxorubicin—kidney cancer	6.08e-05	0.000423	CcSEcCtD
Quinine—Visual impairment—Doxorubicin—kidney cancer	5.98e-05	0.000416	CcSEcCtD
Quinine—Asthenia—Paclitaxel—kidney cancer	5.98e-05	0.000416	CcSEcCtD
Quinine—Decreased appetite—Capecitabine—kidney cancer	5.94e-05	0.000414	CcSEcCtD
Quinine—Nausea—Gemcitabine—kidney cancer	5.91e-05	0.000411	CcSEcCtD
Quinine—Gastrointestinal disorder—Capecitabine—kidney cancer	5.9e-05	0.000411	CcSEcCtD
Quinine—Pruritus—Paclitaxel—kidney cancer	5.89e-05	0.00041	CcSEcCtD
Quinine—Erythema multiforme—Doxorubicin—kidney cancer	5.87e-05	0.000408	CcSEcCtD
Quinine—Eye disorder—Doxorubicin—kidney cancer	5.8e-05	0.000404	CcSEcCtD
Quinine—Tinnitus—Doxorubicin—kidney cancer	5.78e-05	0.000403	CcSEcCtD
Quinine—Flushing—Doxorubicin—kidney cancer	5.76e-05	0.000401	CcSEcCtD
Quinine—Cardiac disorder—Doxorubicin—kidney cancer	5.76e-05	0.000401	CcSEcCtD
Quinine—Diarrhoea—Paclitaxel—kidney cancer	5.7e-05	0.000397	CcSEcCtD
Quinine—Feeling abnormal—Capecitabine—kidney cancer	5.63e-05	0.000392	CcSEcCtD
Quinine—Immune system disorder—Doxorubicin—kidney cancer	5.6e-05	0.00039	CcSEcCtD
Quinine—Gastrointestinal pain—Capecitabine—kidney cancer	5.59e-05	0.000389	CcSEcCtD
Quinine—Mediastinal disorder—Doxorubicin—kidney cancer	5.59e-05	0.000389	CcSEcCtD
Quinine—Chills—Doxorubicin—kidney cancer	5.57e-05	0.000388	CcSEcCtD
Quinine—Dizziness—Paclitaxel—kidney cancer	5.51e-05	0.000384	CcSEcCtD
Quinine—Mental disorder—Doxorubicin—kidney cancer	5.44e-05	0.000378	CcSEcCtD
Quinine—Urticaria—Capecitabine—kidney cancer	5.43e-05	0.000378	CcSEcCtD
Quinine—Body temperature increased—Capecitabine—kidney cancer	5.41e-05	0.000376	CcSEcCtD
Quinine—Abdominal pain—Capecitabine—kidney cancer	5.41e-05	0.000376	CcSEcCtD
Quinine—Erythema—Doxorubicin—kidney cancer	5.4e-05	0.000376	CcSEcCtD
Quinine—Malnutrition—Doxorubicin—kidney cancer	5.4e-05	0.000376	CcSEcCtD
Quinine—Vomiting—Paclitaxel—kidney cancer	5.3e-05	0.000369	CcSEcCtD
Quinine—Rash—Paclitaxel—kidney cancer	5.25e-05	0.000366	CcSEcCtD
Quinine—Dermatitis—Paclitaxel—kidney cancer	5.25e-05	0.000365	CcSEcCtD
Quinine—Headache—Paclitaxel—kidney cancer	5.22e-05	0.000363	CcSEcCtD
Quinine—Vision blurred—Doxorubicin—kidney cancer	5.09e-05	0.000354	CcSEcCtD
Quinine—Hypersensitivity—Capecitabine—kidney cancer	5.04e-05	0.000351	CcSEcCtD
Quinine—Agitation—Doxorubicin—kidney cancer	4.96e-05	0.000345	CcSEcCtD
Quinine—Nausea—Paclitaxel—kidney cancer	4.95e-05	0.000345	CcSEcCtD
Quinine—Asthenia—Capecitabine—kidney cancer	4.91e-05	0.000342	CcSEcCtD
Quinine—Vertigo—Doxorubicin—kidney cancer	4.85e-05	0.000338	CcSEcCtD
Quinine—Syncope—Doxorubicin—kidney cancer	4.84e-05	0.000337	CcSEcCtD
Quinine—Pruritus—Capecitabine—kidney cancer	4.84e-05	0.000337	CcSEcCtD
Quinine—Leukopenia—Doxorubicin—kidney cancer	4.83e-05	0.000337	CcSEcCtD
Quinine—Palpitations—Doxorubicin—kidney cancer	4.77e-05	0.000332	CcSEcCtD
Quinine—Loss of consciousness—Doxorubicin—kidney cancer	4.75e-05	0.00033	CcSEcCtD
Quinine—Convulsion—Doxorubicin—kidney cancer	4.68e-05	0.000326	CcSEcCtD
Quinine—Diarrhoea—Capecitabine—kidney cancer	4.68e-05	0.000326	CcSEcCtD
Quinine—Chest pain—Doxorubicin—kidney cancer	4.6e-05	0.00032	CcSEcCtD
Quinine—Myalgia—Doxorubicin—kidney cancer	4.6e-05	0.00032	CcSEcCtD
Quinine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	4.57e-05	0.000318	CcSEcCtD
Quinine—Dizziness—Capecitabine—kidney cancer	4.52e-05	0.000315	CcSEcCtD
Quinine—Confusional state—Doxorubicin—kidney cancer	4.44e-05	0.000309	CcSEcCtD
Quinine—Oedema—Doxorubicin—kidney cancer	4.41e-05	0.000307	CcSEcCtD
Quinine—Vomiting—Capecitabine—kidney cancer	4.35e-05	0.000303	CcSEcCtD
Quinine—Shock—Doxorubicin—kidney cancer	4.34e-05	0.000302	CcSEcCtD
Quinine—Nervous system disorder—Doxorubicin—kidney cancer	4.32e-05	0.000301	CcSEcCtD
Quinine—Thrombocytopenia—Doxorubicin—kidney cancer	4.32e-05	0.0003	CcSEcCtD
Quinine—Rash—Capecitabine—kidney cancer	4.31e-05	0.0003	CcSEcCtD
Quinine—Dermatitis—Capecitabine—kidney cancer	4.31e-05	0.0003	CcSEcCtD
Quinine—Tachycardia—Doxorubicin—kidney cancer	4.3e-05	0.000299	CcSEcCtD
Quinine—Headache—Capecitabine—kidney cancer	4.28e-05	0.000298	CcSEcCtD
Quinine—Skin disorder—Doxorubicin—kidney cancer	4.28e-05	0.000298	CcSEcCtD
Quinine—Hyperhidrosis—Doxorubicin—kidney cancer	4.26e-05	0.000297	CcSEcCtD
Quinine—Anorexia—Doxorubicin—kidney cancer	4.2e-05	0.000292	CcSEcCtD
Quinine—Hypotension—Doxorubicin—kidney cancer	4.12e-05	0.000287	CcSEcCtD
Quinine—Nausea—Capecitabine—kidney cancer	4.06e-05	0.000283	CcSEcCtD
Quinine—Musculoskeletal discomfort—Doxorubicin—kidney cancer	4.02e-05	0.00028	CcSEcCtD
Quinine—Dyspnoea—Doxorubicin—kidney cancer	3.93e-05	0.000274	CcSEcCtD
Quinine—Decreased appetite—Doxorubicin—kidney cancer	3.83e-05	0.000267	CcSEcCtD
Quinine—Gastrointestinal disorder—Doxorubicin—kidney cancer	3.81e-05	0.000265	CcSEcCtD
Quinine—Feeling abnormal—Doxorubicin—kidney cancer	3.63e-05	0.000253	CcSEcCtD
Quinine—Gastrointestinal pain—Doxorubicin—kidney cancer	3.6e-05	0.000251	CcSEcCtD
Quinine—Urticaria—Doxorubicin—kidney cancer	3.5e-05	0.000244	CcSEcCtD
Quinine—Abdominal pain—Doxorubicin—kidney cancer	3.48e-05	0.000243	CcSEcCtD
Quinine—Body temperature increased—Doxorubicin—kidney cancer	3.48e-05	0.000243	CcSEcCtD
Quinine—Hypersensitivity—Doxorubicin—kidney cancer	3.25e-05	0.000226	CcSEcCtD
Quinine—Asthenia—Doxorubicin—kidney cancer	3.16e-05	0.00022	CcSEcCtD
Quinine—Pruritus—Doxorubicin—kidney cancer	3.12e-05	0.000217	CcSEcCtD
Quinine—Diarrhoea—Doxorubicin—kidney cancer	3.02e-05	0.00021	CcSEcCtD
Quinine—Dizziness—Doxorubicin—kidney cancer	2.91e-05	0.000203	CcSEcCtD
Quinine—Vomiting—Doxorubicin—kidney cancer	2.8e-05	0.000195	CcSEcCtD
Quinine—Rash—Doxorubicin—kidney cancer	2.78e-05	0.000193	CcSEcCtD
Quinine—Dermatitis—Doxorubicin—kidney cancer	2.78e-05	0.000193	CcSEcCtD
Quinine—Headache—Doxorubicin—kidney cancer	2.76e-05	0.000192	CcSEcCtD
Quinine—Nausea—Doxorubicin—kidney cancer	2.62e-05	0.000182	CcSEcCtD
Quinine—CYP3A7—Metabolism—GSTM1—kidney cancer	6.06e-06	0.000125	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—GSTM1—kidney cancer	6.05e-06	0.000124	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—FLT1—kidney cancer	6.03e-06	0.000124	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.02e-06	0.000124	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GPC3—kidney cancer	6.02e-06	0.000124	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	6.02e-06	0.000124	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—BCHE—kidney cancer	6e-06	0.000123	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—BCHE—kidney cancer	5.99e-06	0.000123	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PSMD7—kidney cancer	5.97e-06	0.000123	CbGpPWpGaD
Quinine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	5.97e-06	0.000123	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—GSTT1—kidney cancer	5.96e-06	0.000122	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—ACHE—kidney cancer	5.96e-06	0.000122	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—SLC5A5—kidney cancer	5.93e-06	0.000122	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—SLC5A5—kidney cancer	5.92e-06	0.000122	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—CA2—kidney cancer	5.85e-06	0.00012	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—ITPR2—kidney cancer	5.83e-06	0.00012	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—ABCB1—kidney cancer	5.81e-06	0.000119	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—CRABP1—kidney cancer	5.77e-06	0.000119	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—CA9—kidney cancer	5.75e-06	0.000118	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—CYP1A1—kidney cancer	5.75e-06	0.000118	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—CYP1A1—kidney cancer	5.74e-06	0.000118	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—SLC2A1—kidney cancer	5.73e-06	0.000118	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—CRABP1—kidney cancer	5.72e-06	0.000118	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—SLC2A1—kidney cancer	5.72e-06	0.000117	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—ALAD—kidney cancer	5.7e-06	0.000117	CbGpPWpGaD
Quinine—ABCB1—Metabolism—ITPR2—kidney cancer	5.69e-06	0.000117	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—POMC—kidney cancer	5.69e-06	0.000117	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—BCHE—kidney cancer	5.66e-06	0.000116	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—GSTM1—kidney cancer	5.64e-06	0.000116	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—SCARB1—kidney cancer	5.64e-06	0.000116	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	5.62e-06	0.000115	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—SLC5A5—kidney cancer	5.59e-06	0.000115	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PAK1—kidney cancer	5.59e-06	0.000115	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—JUNB—kidney cancer	5.59e-06	0.000115	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PTGS1—kidney cancer	5.58e-06	0.000115	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—ST3GAL2—kidney cancer	5.57e-06	0.000114	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PSMD7—kidney cancer	5.48e-06	0.000112	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—POMC—kidney cancer	5.46e-06	0.000112	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—ALDH1A1—kidney cancer	5.44e-06	0.000112	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—SLC2A1—kidney cancer	5.4e-06	0.000111	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.38e-06	0.00011	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—ITPR2—kidney cancer	5.36e-06	0.00011	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—CYP1A1—kidney cancer	5.35e-06	0.00011	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—GSTT1—kidney cancer	5.32e-06	0.000109	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—ACHE—kidney cancer	5.32e-06	0.000109	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—ITPR2—kidney cancer	5.32e-06	0.000109	CbGpPWpGaD
Quinine—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.24e-06	0.000108	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PGK1—kidney cancer	5.22e-06	0.000107	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—SLC5A3—kidney cancer	5.22e-06	0.000107	CbGpPWpGaD
Quinine—ABCB1—Metabolism—ACHE—kidney cancer	5.19e-06	0.000107	CbGpPWpGaD
Quinine—ABCB1—Metabolism—GSTT1—kidney cancer	5.19e-06	0.000107	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—BCHE—kidney cancer	5.19e-06	0.000107	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—POMC—kidney cancer	5.16e-06	0.000106	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—SLC5A5—kidney cancer	5.13e-06	0.000105	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—LDHB—kidney cancer	5.12e-06	0.000105	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—SCARB1—kidney cancer	5.03e-06	0.000103	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PTGS1—kidney cancer	4.98e-06	0.000102	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—SLC2A1—kidney cancer	4.95e-06	0.000102	CbGpPWpGaD
Quinine—ABCB1—Metabolism—SCARB1—kidney cancer	4.91e-06	0.000101	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.9e-06	0.000101	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—ACHE—kidney cancer	4.89e-06	0.000101	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—GSTT1—kidney cancer	4.89e-06	0.000101	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—CRABP1—kidney cancer	4.89e-06	0.0001	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PSMD7—kidney cancer	4.89e-06	0.0001	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PTGS1—kidney cancer	4.86e-06	9.99e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—ACHE—kidney cancer	4.85e-06	9.96e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—GSTT1—kidney cancer	4.85e-06	9.96e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.8e-06	9.87e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—GSTP1—kidney cancer	4.78e-06	9.82e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PSMD7—kidney cancer	4.77e-06	9.8e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—GSTP1—kidney cancer	4.77e-06	9.8e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—BCHE—kidney cancer	4.63e-06	9.52e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—SCARB1—kidney cancer	4.63e-06	9.51e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—SCARB1—kidney cancer	4.59e-06	9.43e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PTGS1—kidney cancer	4.58e-06	9.42e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—SLC5A5—kidney cancer	4.58e-06	9.4e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.57e-06	9.39e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—IGF2—kidney cancer	4.57e-06	9.39e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CDKN2B—kidney cancer	4.55e-06	9.35e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—ITPR2—kidney cancer	4.54e-06	9.34e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PTGS1—kidney cancer	4.54e-06	9.34e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—ABCB1—kidney cancer	4.52e-06	9.29e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—BCHE—kidney cancer	4.52e-06	9.29e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—ABCB1—kidney cancer	4.51e-06	9.27e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—GSTP1—kidney cancer	4.5e-06	9.26e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PSMD7—kidney cancer	4.5e-06	9.24e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—SLC5A5—kidney cancer	4.47e-06	9.18e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PSMD7—kidney cancer	4.46e-06	9.16e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—CA9—kidney cancer	4.44e-06	9.12e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—SLC2A1—kidney cancer	4.42e-06	9.08e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—IGF1R—kidney cancer	4.42e-06	9.08e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—GSTM1—kidney cancer	4.39e-06	9.02e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—GSTM1—kidney cancer	4.38e-06	9e-05	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—PTGS2—kidney cancer	4.35e-06	8.95e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—SLC2A1—kidney cancer	4.31e-06	8.86e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.29e-06	8.81e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—POMC—kidney cancer	4.28e-06	8.8e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—POMC—kidney cancer	4.28e-06	8.79e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—ABCB1—kidney cancer	4.26e-06	8.76e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—BCHE—kidney cancer	4.26e-06	8.76e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—RAF1—kidney cancer	4.26e-06	8.75e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—BCHE—kidney cancer	4.22e-06	8.68e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—SLC5A5—kidney cancer	4.21e-06	8.65e-05	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—IL2—kidney cancer	4.2e-06	8.64e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.19e-06	8.61e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.19e-06	8.61e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—SLC5A5—kidney cancer	4.17e-06	8.57e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—CYP1A1—kidney cancer	4.16e-06	8.55e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—CYP1A1—kidney cancer	4.15e-06	8.53e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—GSTT1—kidney cancer	4.14e-06	8.51e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—ACHE—kidney cancer	4.14e-06	8.51e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—GSTM1—kidney cancer	4.14e-06	8.51e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—GSTP1—kidney cancer	4.13e-06	8.49e-05	CbGpPWpGaD
Quinine—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	4.11e-06	8.45e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—SLC2A1—kidney cancer	4.07e-06	8.35e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—SLC2A1—kidney cancer	4.03e-06	8.28e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—POMC—kidney cancer	3.99e-06	8.19e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—SCARB1—kidney cancer	3.92e-06	8.06e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.91e-06	8.03e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—ABCB1—kidney cancer	3.91e-06	8.03e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PTGS1—kidney cancer	3.88e-06	7.98e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—IL2—kidney cancer	3.82e-06	7.84e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PSMD7—kidney cancer	3.81e-06	7.82e-05	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—PTEN—kidney cancer	3.8e-06	7.8e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—GSTM1—kidney cancer	3.8e-06	7.8e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—CRABP1—kidney cancer	3.77e-06	7.75e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.74e-06	7.68e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—GSTP1—kidney cancer	3.69e-06	7.57e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—HIF1A—kidney cancer	3.64e-06	7.47e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—TSC2—kidney cancer	3.63e-06	7.45e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—BCHE—kidney cancer	3.61e-06	7.42e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—GSTP1—kidney cancer	3.6e-06	7.39e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—CYP1A1—kidney cancer	3.6e-06	7.39e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—SLC5A5—kidney cancer	3.57e-06	7.33e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—ITPR2—kidney cancer	3.51e-06	7.21e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—ABCB1—kidney cancer	3.49e-06	7.17e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—KDR—kidney cancer	3.48e-06	7.15e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—SLC2A1—kidney cancer	3.44e-06	7.08e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PTGS2—kidney cancer	3.42e-06	7.02e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PTGS2—kidney cancer	3.41e-06	7.01e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.41e-06	7.01e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—GSTP1—kidney cancer	3.39e-06	6.97e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—GSTM1—kidney cancer	3.39e-06	6.96e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—GSTP1—kidney cancer	3.36e-06	6.91e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.34e-06	6.86e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—GSTM1—kidney cancer	3.31e-06	6.79e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.22e-06	6.62e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—CYP1A1—kidney cancer	3.21e-06	6.6e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—ABCB1—kidney cancer	3.21e-06	6.59e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—APC—kidney cancer	3.2e-06	6.58e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—KIT—kidney cancer	3.2e-06	6.58e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GSTT1—kidney cancer	3.2e-06	6.57e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—ACHE—kidney cancer	3.2e-06	6.57e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—ABCB1—kidney cancer	3.18e-06	6.54e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PTGS2—kidney cancer	3.18e-06	6.53e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—CYP1A1—kidney cancer	3.13e-06	6.44e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—GSTM1—kidney cancer	3.12e-06	6.4e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—POMC—kidney cancer	3.1e-06	6.38e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—POMC—kidney cancer	3.1e-06	6.36e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—GSTM1—kidney cancer	3.09e-06	6.35e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—MAPK3—kidney cancer	3.07e-06	6.3e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—POMC—kidney cancer	3.05e-06	6.27e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—SCARB1—kidney cancer	3.03e-06	6.22e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—BRAF—kidney cancer	3.01e-06	6.19e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PTGS1—kidney cancer	3e-06	6.16e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PTEN—kidney cancer	2.98e-06	6.12e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PTEN—kidney cancer	2.98e-06	6.11e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.96e-06	6.07e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—CYP1A1—kidney cancer	2.95e-06	6.07e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PSMD7—kidney cancer	2.94e-06	6.04e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—CYP1A1—kidney cancer	2.93e-06	6.02e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—POMC—kidney cancer	2.93e-06	6.01e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—MAPK1—kidney cancer	2.92e-06	6e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	2.91e-06	5.99e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—GSTP1—kidney cancer	2.87e-06	5.9e-05	CbGpPWpGaD
Quinine—CHRM2—GPCR downstream signaling—PIK3CA—kidney cancer	2.79e-06	5.73e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—BCHE—kidney cancer	2.79e-06	5.72e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PTEN—kidney cancer	2.77e-06	5.7e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—KRAS—kidney cancer	2.76e-06	5.67e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.75e-06	5.65e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—ABCB1—kidney cancer	2.72e-06	5.59e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—POMC—kidney cancer	2.68e-06	5.51e-05	CbGpPWpGaD
Quinine—SLCO1A2—Metabolism—PIK3CA—kidney cancer	2.68e-06	5.5e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.66e-06	5.46e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—GSTM1—kidney cancer	2.64e-06	5.42e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.64e-06	5.42e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling by GPCR—PIK3CA—kidney cancer	2.53e-06	5.21e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—RAF1—kidney cancer	2.51e-06	5.17e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—RELA—kidney cancer	2.5e-06	5.14e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—CYP1A1—kidney cancer	2.5e-06	5.14e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—ERBB2—kidney cancer	2.49e-06	5.11e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PTGS2—kidney cancer	2.48e-06	5.09e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PTGS2—kidney cancer	2.47e-06	5.08e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MTOR—kidney cancer	2.46e-06	5.04e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.41e-06	4.94e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—POMC—kidney cancer	2.39e-06	4.92e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—POMC—kidney cancer	2.34e-06	4.8e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PTGS2—kidney cancer	2.33e-06	4.79e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CDKN1B—kidney cancer	2.3e-06	4.73e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—IL2—kidney cancer	2.25e-06	4.63e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GSTP1—kidney cancer	2.22e-06	4.55e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—POMC—kidney cancer	2.2e-06	4.52e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CCND1—kidney cancer	2.2e-06	4.52e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—JUN—kidney cancer	2.19e-06	4.51e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—POMC—kidney cancer	2.18e-06	4.49e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—CTNNB1—kidney cancer	2.18e-06	4.47e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PTEN—kidney cancer	2.16e-06	4.44e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PTEN—kidney cancer	2.15e-06	4.43e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PTGS2—kidney cancer	2.14e-06	4.4e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PTEN—kidney cancer	2.12e-06	4.36e-05	CbGpPWpGaD
Quinine—CYP3A7—Metabolism—PIK3CA—kidney cancer	2.1e-06	4.32e-05	CbGpPWpGaD
Quinine—SLC22A2—Metabolism—PIK3CA—kidney cancer	2.1e-06	4.31e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—ABCB1—kidney cancer	2.1e-06	4.31e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.06e-06	4.22e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—GSTM1—kidney cancer	2.04e-06	4.19e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PTEN—kidney cancer	2.04e-06	4.18e-05	CbGpPWpGaD
Quinine—SLC22A1—Metabolism—PIK3CA—kidney cancer	1.96e-06	4.02e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—CYP1A1—kidney cancer	1.93e-06	3.97e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—VEGFA—kidney cancer	1.92e-06	3.94e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PTGS2—kidney cancer	1.91e-06	3.92e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PTEN—kidney cancer	1.87e-06	3.83e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—POMC—kidney cancer	1.87e-06	3.83e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PTGS2—kidney cancer	1.86e-06	3.83e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MAPK3—kidney cancer	1.81e-06	3.72e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MYC—kidney cancer	1.76e-06	3.62e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PTGS2—kidney cancer	1.76e-06	3.61e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PTGS2—kidney cancer	1.74e-06	3.58e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—MAPK1—kidney cancer	1.72e-06	3.54e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PTEN—kidney cancer	1.67e-06	3.42e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—KRAS—kidney cancer	1.63e-06	3.35e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PTEN—kidney cancer	1.63e-06	3.34e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PTEN—kidney cancer	1.53e-06	3.15e-05	CbGpPWpGaD
Quinine—CYP2E1—Metabolism—PIK3CA—kidney cancer	1.52e-06	3.13e-05	CbGpPWpGaD
Quinine—CYP3A5—Metabolism—PIK3CA—kidney cancer	1.52e-06	3.12e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PTEN—kidney cancer	1.52e-06	3.12e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—PIK3CA—kidney cancer	1.5e-06	3.07e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PTGS2—kidney cancer	1.49e-06	3.06e-05	CbGpPWpGaD
Quinine—CHRM2—Signaling Pathways—TP53—kidney cancer	1.45e-06	2.97e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—POMC—kidney cancer	1.44e-06	2.96e-05	CbGpPWpGaD
Quinine—CYP1A1—Metabolism—PIK3CA—kidney cancer	1.44e-06	2.95e-05	CbGpPWpGaD
Quinine—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.32e-06	2.7e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PTEN—kidney cancer	1.3e-06	2.67e-05	CbGpPWpGaD
Quinine—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.17e-06	2.41e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PTGS2—kidney cancer	1.15e-06	2.36e-05	CbGpPWpGaD
Quinine—ABCB1—Metabolism—PIK3CA—kidney cancer	1.15e-06	2.36e-05	CbGpPWpGaD
Quinine—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.08e-06	2.22e-05	CbGpPWpGaD
Quinine—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.07e-06	2.2e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PTEN—kidney cancer	1e-06	2.06e-05	CbGpPWpGaD
Quinine—CYP1A2—Metabolism—PIK3CA—kidney cancer	9.15e-07	1.88e-05	CbGpPWpGaD
Quinine—CYP3A4—Metabolism—PIK3CA—kidney cancer	7.07e-07	1.45e-05	CbGpPWpGaD
